Estonia vs United States of America: Share of adolescent girls vaccinated against human papillomavirus
Estonia
63.0%
in 2024
United States of America
65.0%
in 2024
Estonia rank
41st
United States of America rank
38th
Share of adolescent girls vaccinated against human papillomavirus over time
- Estonia
- United States of America
How they compare
United States of America currently reports 65.0% against 63.0% in Estonia, a difference of 2.0%.
Across all 6 years both countries report, United States of America has been ahead every year.
Estonia ranks 41st and United States of America ranks 38th of 74 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.0% | 62.0% | 14.0% | United States of America |
| 2020s | 56.6% | 66.2% | 9.6% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Estonia or United States of America?
- United States of America, at 65.0% against 63.0% in Estonia as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Estonia and United States of America?
- 2.0%, with United States of America ahead.
- How many years of comparable data are there for Estonia and United States of America?
- 6 years are reported by both, from 2019 to 2024.
- How do Estonia and United States of America rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Estonia ranks 41st and United States of America ranks 38th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.